Oxford professor Adrian Hill (Eddie Keogh/Reuters via Alamy)

Ox­ford and No­vavax tout 75%+ ef­fi­ca­cy for malar­ia vac­cine, best­ing Glax­o­SmithK­line in long hunt to in­oc­u­late against the dead­ly par­a­site

No­vavax and Ox­ford’s Jen­ner In­sti­tute have spent the last 16 months mak­ing head­lines for their Covid-19 vac­cines. But, qui­et­ly, the two groups have al­so spent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.